Solid Biosciences Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Solid Biosciences Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2016 to Q4 2023.
  • Solid Biosciences Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending December 31, 2023 was $126M, a 40.2% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $126M -$85.2M -40.2% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $212M +$3.46M +1.66% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $208M +$76.1M +57.6% Dec 31, 2021 10-K 2024-03-13
Q4 2020 $132M +$52M +65% Dec 31, 2020 10-K 2024-03-13
Q4 2019 $80M -$45.1M -36.1% Dec 31, 2019 10-K 2023-03-23
Q4 2018 $125M +$184M Dec 31, 2018 10-K 2022-03-14
Q4 2017 -$59.3M -$21.4M -56.4% Dec 31, 2017 10-K 2021-03-15
Q4 2016 -$37.9M Dec 31, 2016 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.